<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02127853</url>
  </required_header>
  <id_info>
    <org_study_id>SerialCataractGaba</org_study_id>
    <nct_id>NCT02127853</nct_id>
  </id_info>
  <brief_title>Effect of Gabapentin on Pain of the Second Cataract Surgery</brief_title>
  <official_title>The Effect of Pretreated Gabapentin on Hyeralgesia Occurring in the Second Operation in Staged Bilateral Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gabapentin pretreatment may reduce hyperalgesia occurring at the second surgery in serial,
      bilateral cataract surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperalgesia occurring at the second operation in bilateral eye surgery is well known, and
      mechanism of central sensitization might be involved. Gabapentin is known to lower the effect
      of central sensitization, and its effect on acute postoperative pain has been reported.
      Therefore, pretreatment of gabapentin after first operation may reduce the pain at second
      operation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>proportion of subjects who answer that &quot;pain was greater&quot; in the second eye surgery</measure>
    <time_frame>Intra operative (pain while fluid injection to anterior chamber)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>perioperative pain</measure>
    <time_frame>end of surgery, post-op 1hr at PACU, at out-patient ward, post-op 1 day</time_frame>
    <description>evaluation of overall perioperative pain</description>
  </secondary_outcome>
  <other_outcome>
    <measure>satisfaction</measure>
    <time_frame>intra operative</time_frame>
    <description>evaluation of satisfaction of both operator and patient</description>
  </other_outcome>
  <other_outcome>
    <measure>anxiety</measure>
    <time_frame>baseline (at OR room arrival, just before sterile draping)</time_frame>
    <description>evaluation of patient's anxiety</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Hyperalgesia</condition>
  <arm_group>
    <arm_group_label>Gabapentin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>gabapentin pretreatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo drug pretreatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gabapentin</intervention_name>
    <description>100 mg tid of gabapentin is prescribed to the patient for 1 week after the first eye surgery</description>
    <arm_group_label>Gabapentin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>the same regimen of placebo drug is prescribed to the patient for 1 week after the first eye surgery</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient of ASA(American Cociety of Anesthesiology) class I, II, III between age 20 to
             80, scheduled for serial bilateral cataract surgery(1 weel interval)

        Exclusion Criteria:

          -  refuse to participate

          -  BMI&lt;16 or BMI &gt;30

          -  severe cardiovascular, pulmonary, renal disease

          -  alcohol or drug abuse

          -  currently taking CNS(central nervous system) inhibitory drugs

          -  taking antiacids

          -  depressive disorder pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Heepyoung Park, MD,PhD</last_name>
    <phone>82-2-2072-2466</phone>
    <email>hppark@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eugene Kim, MD</last_name>
    <phone>82-2-2072-2469</phone>
    <email>tomomie@hanmail.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-799</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heepyoung Park, MD, PhD</last_name>
      <phone>82-2-2072-2466</phone>
      <email>hppark@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Eugene Kim, MD</last_name>
      <phone>82-2-2072-2469</phone>
      <email>tomomie@hanmail.net</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2014</study_first_submitted>
  <study_first_submitted_qc>April 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2014</study_first_posted>
  <last_update_submitted>May 10, 2015</last_update_submitted>
  <last_update_submitted_qc>May 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Pyoung Park</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <keyword>serial cataract surgery</keyword>
  <keyword>hyperalgesia</keyword>
  <keyword>gabapentin</keyword>
  <keyword>central sensitization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Hyperalgesia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

